A Review of Neurological Symptoms in Long COVID and Clinical Management
- PMID: 37068519
- DOI: 10.1055/s-0043-1767781
A Review of Neurological Symptoms in Long COVID and Clinical Management
Abstract
Long COVID is a clinical diagnosis generally referring to the persistence or development of new symptoms, affecting multiple organ systems after SARS-CoV-2 COVID-19 infection. Long COVID is thought to affect ∼20% of people after infection, including all age ranges and severity of infection. Fatigue, postexertional malaise, and respiratory and cardiac symptoms are commonly described. Neurological symptoms such as cognitive changes, sensory disturbances, headaches, and dysautonomia are common as well. The underlying pathophysiology remains unclear but immune dysregulation, autoimmunity, persistent viral reservoirs, and microvascular dysfunction have been implicated. As there are no tests at this time to diagnose long COVID, work-up should be focused on assessing reversible or treatable causes of symptoms. Furthermore, no treatments for long COVID currently exist, and management remains focused on a multimodal approach and symptom management, with many people showing improvement in symptoms over time.
Thieme. All rights reserved.
Conflict of interest statement
None declared.
Similar articles
-
Cardiovascular Considerations in the Management of People With Suspected Long COVID.Can J Cardiol. 2023 Jun;39(6):741-753. doi: 10.1016/j.cjca.2023.04.003. Epub 2023 Apr 6. Can J Cardiol. 2023. PMID: 37030518 Free PMC article. Review.
-
Mechanistic Insights Into Long Covid: Viral Persistence, Immune Dysregulation, and Multi-Organ Dysfunction.Compr Physiol. 2025 Jun;15(3):e70019. doi: 10.1002/cph4.70019. Compr Physiol. 2025. PMID: 40474772 Review.
-
Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Autoimmunity in Long COVID.Viruses. 2023 Jan 31;15(2):400. doi: 10.3390/v15020400. Viruses. 2023. PMID: 36851614 Free PMC article. Review.
-
Pathogenesis Underlying Neurological Manifestations of Long COVID Syndrome and Potential Therapeutics.Cells. 2023 Mar 6;12(5):816. doi: 10.3390/cells12050816. Cells. 2023. PMID: 36899952 Free PMC article. Review.
-
Pediatric Long-COVID: A Review of the Definition, Epidemiology, Presentation, and Pathophysiology.Pediatr Ann. 2022 Nov;51(11):e416-e420. doi: 10.3928/19382359-20220913-06. Epub 2022 Nov 1. Pediatr Ann. 2022. PMID: 36343180 Review.
Cited by
-
Neutrophil extracellular traps and long COVID.Front Immunol. 2023 Sep 27;14:1254310. doi: 10.3389/fimmu.2023.1254310. eCollection 2023. Front Immunol. 2023. PMID: 37828990 Free PMC article. Review.
-
Neuropsychiatric Manifestations of Long COVID-19: A Narrative Review of Clinical Aspects and Therapeutic Approaches.Life (Basel). 2025 Mar 11;15(3):439. doi: 10.3390/life15030439. Life (Basel). 2025. PMID: 40141784 Free PMC article. Review.
-
Similarity to Self-Antigens Shapes Epitope Recognition from Viruses Under Autoimmune and Infectious Disease.Int J Mol Sci. 2025 Jun 24;26(13):6041. doi: 10.3390/ijms26136041. Int J Mol Sci. 2025. PMID: 40649820 Free PMC article.
-
Neurologic manifestations of Long COVID in Colombia: a comparative analysis of post-hospitalization vs. non-hospitalized patients.Front Hum Neurosci. 2024 Aug 13;18:1450110. doi: 10.3389/fnhum.2024.1450110. eCollection 2024. Front Hum Neurosci. 2024. PMID: 39192882 Free PMC article.
-
Management of cognitive impairment associated with post-COVID-19 syndrome: recommendations for primary care.Front Pharmacol. 2024 Apr 22;15:1338235. doi: 10.3389/fphar.2024.1338235. eCollection 2024. Front Pharmacol. 2024. PMID: 38711990 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous